Abstract
The antinociceptive effects of controlled release amitriptyline, desipramine, and placebo pellets were studied over 3 weeks using the hot plate method in 45 rats. Animals treated with desipramine at total doses of 50 mg (8 mg/kg/day) and 100 mg (16 mg/kg/day) displayed analgesia for up to 48 hours compared with the matching placebo groups. Amitriptyline did not produce significant analgesia at the same doses. By 72 hours until the final evaluation period at 21 days, the antinociceptive action of desipramine was no longer evident. These results suggest that relatively small continuously released doses of desipramine produce analgesia within 24 hours in this animal model, but an apparent analgesic tolerance develops within 3 days.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alcoff J., Jones E., Rust P., Newman R. Controlled trial of imipramine for chronic low back pain. J Fam Pract. 1982 May;14(5):841–846. [PubMed] [Google Scholar]
- Botney M., Fields H. L. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol. 1983 Feb;13(2):160–164. doi: 10.1002/ana.410130209. [DOI] [PubMed] [Google Scholar]
- Carasso R. L., Yehuda S., Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci. 1979;9(3):191–194. doi: 10.3109/00207457909147672. [DOI] [PubMed] [Google Scholar]
- Couch J. R., Ziegler D. K., Hassanein R. Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects. Neurology. 1976 Feb;26(2):121–127. doi: 10.1212/wnl.26.2.121. [DOI] [PubMed] [Google Scholar]
- Dental sealants in the prevention of tooth decay. NIH Consensus Development Conference summary. Br Dent J. 1984 Apr 21;156(8):295–298. doi: 10.1038/sj.bdj.4805335. [DOI] [PubMed] [Google Scholar]
- Gessel A. H. Electromygraphic biofeedback and tricyclic antidepressants in myofascial pain-dysfunction syndrome: psychological predictors of outcome. J Am Dent Assoc. 1975 Nov;91(5):1048–1052. doi: 10.14219/jada.archive.1975.0512. [DOI] [PubMed] [Google Scholar]
- Gonzalez J. P., Sewell R. D., Spencer P. S. Antinociceptive activity of opiates in the presence of the antidepressant agent nomifensine. Neuropharmacology. 1980 Jul;19(7):613–618. doi: 10.1016/0028-3908(80)90034-9. [DOI] [PubMed] [Google Scholar]
- Goss A. N., Speculand B., Hallet E. Diagnosis of temporomandibular joint pain in patients seen at a pain clinic. J Oral Maxillofac Surg. 1985 Feb;43(2):110–114. doi: 10.1016/0278-2391(85)90057-6. [DOI] [PubMed] [Google Scholar]
- Gregg J. M. Post-traumatic trigeminal neuralgia: response to physiologic, surgical and pharmacologic therapies. Int Dent J. 1978 Mar;28(1):43–51. [PubMed] [Google Scholar]
- Hameroff S. R., Cork R. C., Scherer K., Crago B. R., Neuman C., Womble J. R., Davis T. P. Doxepin effects on chronic pain, depression and plasma opioids. J Clin Psychiatry. 1982 Aug;43(8 Pt 2):22–27. [PubMed] [Google Scholar]
- Hersh E. V. Tricyclic antidepressant drugs: pharmacologic implications in the treatment of chronic orofacial pain. Compendium. 1987 Oct;8(9):688, 690, 692-4. [PubMed] [Google Scholar]
- Hess R. W., Hardman S. L., Shirachi D. Y., Taubert K. A. Comparison between osmotic mini-pumps and controlled release pellets in chronic clonidine administration in the spontaneously hypertensive rat. Proc West Pharmacol Soc. 1985;28:97–101. [PubMed] [Google Scholar]
- Jenkins D. G., Ebbutt A. F., Evans C. D. Tofranil in the treatment of low back pain. J Int Med Res. 1976;4(2 Suppl):28–40. [PubMed] [Google Scholar]
- Kehl L. J., Wilcox G. L. Anti-nociceptive effect of tricyclic anti-depressants following intrathecal administration. Anesth Prog. 1984 Mar-Apr;31(2):82–84. [PMC free article] [PubMed] [Google Scholar]
- Kellstein D. E., Malseed R. T., Ossipov M. H., Goldstein F. J. Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoamines. Neuropharmacology. 1988 Jan;27(1):1–14. doi: 10.1016/0028-3908(88)90194-3. [DOI] [PubMed] [Google Scholar]
- Lin M. T., Chandra A., Chi M. L., Kau C. L. Effects of increasing serotonergic receptor activity in brain on analgesic activity in rats. Exp Neurol. 1980 Jun;68(3):548–554. doi: 10.1016/0014-4886(80)90108-9. [DOI] [PubMed] [Google Scholar]
- McCain H. W. Quantitating antinociception with experimentally induced pain. Terminology, guidelines, and in vivo models. Dent Clin North Am. 1987 Oct;31(4):563–578. [PubMed] [Google Scholar]
- Munemura M., Agui T., Sibley D. R. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland. Endocrinology. 1989 Jan;124(1):346–355. doi: 10.1210/endo-124-1-346. [DOI] [PubMed] [Google Scholar]
- Ossipov M. H., Malseed R. T., Goldstein F. J. Augmentation of central and peripheral morphine analgesia by desipramine. Arch Int Pharmacodyn Ther. 1982 Oct;259(2):222–229. [PubMed] [Google Scholar]
- Patil A. R. Melting of anesthesia circuit by humidifier. Another cause of "ventilator disconnect". Anesth Prog. 1989 Mar-Apr;36(2):63–65. [PMC free article] [PubMed] [Google Scholar]
- Reichenberg K., Gaillard-Plaza G., Montastruc J. L. Influence of naloxone on the antinociceptive effects of some antidepressant drugs. Arch Int Pharmacodyn Ther. 1985 May;275(1):78–85. [PubMed] [Google Scholar]
- Singer E. Pain control in dentistry: management of chronic orofacial pain. Compendium. 1987 Feb;8(2):114, 116-8, 120-2. [PubMed] [Google Scholar]
- Stimmel G. L., Escobar J. I. Antidepressants in chronic pain: a review of efficacy. Pharmacotherapy. 1986 Sep-Oct;6(5):262–267. doi: 10.1002/j.1875-9114.1986.tb03486.x. [DOI] [PubMed] [Google Scholar]
- Watson C. P., Evans R. J., Reed K., Merskey H., Goldsmith L., Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982 Jun;32(6):671–673. doi: 10.1212/wnl.32.6.671. [DOI] [PubMed] [Google Scholar]